The relations of dosimetric parameters with long-term outcomes and late toxicities in advanced T-stage nasopharyngeal carcinoma with IMRT

被引:14
作者
Gou, Xiaoxia [1 ,2 ,3 ,4 ]
Duan, Baofeng [1 ,2 ,3 ]
Shi, Huashan [1 ,2 ,3 ]
Qin, Lei [1 ,2 ,3 ]
Xiao, Jianghong [1 ,2 ,3 ]
Chen, Nianyong [1 ,2 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Head & Neck Oncol, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Radiat Oncol, Ctr Canc, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[4] Zunyi Med Univ, Affiliated Hosp, Dept Head & Neck Oncol, Zunyi, Guizhou, Peoples R China
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2020年 / 42卷 / 01期
关键词
clinical outcomes; dosimetry; intensity-modulated radiation therapy; nasopharyngeal carcinoma; organ at risk; INTENSITY-MODULATED RADIOTHERAPY; TEMPORAL-LOBE INJURY; RADIATION-THERAPY; TUMOR VOLUME; CHEMOTHERAPY; CANCER; SURVIVAL; MODEL; RTOG;
D O I
10.1002/hed.25986
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Balancing the dose requirements between targets and normal tissue is a challenge in radiation of nasopharyngeal carcinoma (NPC). The purpose of this study is to evaluate the dosimetric parameters and clinical outcomes in NPC. Methods We presented a retrospective review of patients with T3-4 NPC treated by intensity-modulated radiation therapy (IMRT). Patient characteristics, dosimetric parameters, and the follow-up data for survival and late toxicities were analyzed. Results The 5-year overall survival, local relapse-free survival, and distant metastasis-free survival were 83.0%, 90.1%, and 82.4%, respectively. Multivariate analysis revealed that the volume of involved lymph node was an independent prognostic factor. The volume of primary tumor and the maximal dose were significant factors affecting temporal lobe injury. Conclusions IMRT provided satisfactory local control for advanced T-stage NPC, with acceptable late toxicities. The dose constraint criteria of selected critical structures can be appropriately loosen.
引用
收藏
页码:85 / 92
页数:8
相关论文
共 28 条
[1]   Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study) [J].
Au, K. H. ;
Ngan, Roger K. C. ;
Ng, Alice W. Y. ;
Poon, Darren M. C. ;
Ng, W. T. ;
Yuen, K. T. ;
Lee, Victor H. F. ;
Tung, Stewart Y. ;
Chan, Anthony T. C. ;
Sze, Henry C. K. ;
Cheng, Ashley C. K. ;
Lee, Anne W. M. ;
Kwong, Dora L. W. ;
Tam, Anthony H. P. .
ORAL ONCOLOGY, 2018, 77 :16-21
[2]   Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis [J].
Blanchard, Pierre ;
Lee, Anne ;
Marguet, Sophie ;
Leclercq, Julie ;
Ng, Wai Tong ;
Ma, Jun ;
Chan, Anthony T. C. ;
Huang, Pei-Yu ;
Benhamou, Ellen ;
Zhu, Guopei ;
Chua, Daniel T. T. ;
Chen, Yong ;
Mai, Hai-Qiang ;
Kwong, Dora L. W. ;
Cheah, Shie Lee ;
Moon, James ;
Tung, Yuk ;
Chi, Kwan-Hwa ;
Fountzilas, George ;
Zhang, Li ;
Hui, Edwin Pun ;
Lu, Tai-Xiang ;
Bourhis, Jean ;
Pignon, Jean Pierre .
LANCET ONCOLOGY, 2015, 16 (06) :645-655
[3]   Significance of Primary Tumor Volume and T-stage on Prognosis in Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiation Therapy [J].
Chen, Chuanben ;
Fei, Zhaodong ;
Pan, Jianji ;
Bai, Penggang ;
Chen, Lisha .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (04) :537-542
[4]   Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China [J].
Chen, Yong ;
Sun, Ying ;
Liang, Shao-Bo ;
Zong, Jing-Feng ;
Li, Wen-Fei ;
Chen, Mo ;
Chen, Lei ;
Mao, Yan-Ping ;
Tang, Ling-Long ;
Guo, Ying ;
Lin, Ai-Hua ;
Liu, Meng-Zhong ;
Ma, Jun .
CANCER, 2013, 119 (12) :2230-2238
[5]   Nasopharyngeal carcinoma [J].
Chua, Melvin L. K. ;
Wee, Joseph T. S. ;
Hui, Edwin P. ;
Chan, Anthony T. C. .
LANCET, 2016, 387 (10022) :1012-1024
[6]   TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J].
COX, JD ;
STETZ, J ;
PAJAK, TF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1341-1346
[7]   Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing [J].
Dogan, N ;
King, S ;
Emami, B ;
Mohideen, N ;
Mirkovic, N ;
Leybovich, LB ;
Sethi, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (05) :1480-1491
[8]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[9]   Conformity index:: A review [J].
Feuvret, L ;
Noël, G ;
Mazeron, JJ ;
Bey, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02) :333-342
[10]   Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study [J].
Huang, Juan ;
Kong, Fang-fang ;
Oei, Ronald Wihal ;
Zhai, Rui-ping ;
Hu, Chao-su ;
Ying, Hong-mei .
RADIATION ONCOLOGY, 2019, 14 (1)